Works matching IS 18696953 AND DT 2023 AND VI 14 AND IP 12
Results: 14
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2159, doi. 10.1007/s13300-023-01490-6
- By:
- Publication type:
- Article
Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono Trial.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2173, doi. 10.1007/s13300-023-01485-3
- By:
- Publication type:
- Article
Correction to: Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
The Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Body Composition in Type 2 Diabetes Mellitus: A Narrative Review.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2015, doi. 10.1007/s13300-023-01481-7
- By:
- Publication type:
- Article
A Simplified Screening Model to Predict the Risk of Gestational Diabetes Mellitus in Pregnant Chinese Women.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2143, doi. 10.1007/s13300-023-01480-8
- By:
- Publication type:
- Article
Addressing Insulin Injection Technique: A Follow-up Study of Canadian Patients with Diabetes.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2057, doi. 10.1007/s13300-023-01479-1
- By:
- Publication type:
- Article
Effect of Policaptil Gel Retard on Liver Fat Content and Fibrosis in Adults with Metabolic Syndrome and Type 2 Diabetes: A Non-invasive Approach to MAFLD.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2089, doi. 10.1007/s13300-023-01478-2
- By:
- Publication type:
- Article
Budget Impact Analysis of Intensification with iGlarLixi Compared to Alternative Treatment Strategies Among Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2109, doi. 10.1007/s13300-023-01477-3
- By:
- Publication type:
- Article
Challenging Clinical Perspectives in Type 2 Diabetes with Tirzepatide, a First-in-Class Twincretin.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 1997, doi. 10.1007/s13300-023-01475-5
- By:
- Publication type:
- Article
Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2127, doi. 10.1007/s13300-023-01472-8
- By:
- Publication type:
- Article
Cost per Patient Achieving Treatment Targets and Number Needed to Treat with Tirzepatide Versus Semaglutide 1 mg in Patients with Type 2 Diabetes in the United States.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2045, doi. 10.1007/s13300-023-01470-w
- By:
- Publication type:
- Article
LIVE INDIA: Effectiveness of Gla-100 in a Post hoc Pooled Analysis of FINE ASIA and GOAL Registries.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2075, doi. 10.1007/s13300-023-01469-3
- By:
- Publication type:
- Article
Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic Review.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 1979, doi. 10.1007/s13300-023-01464-8
- By:
- Publication type:
- Article
Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2031, doi. 10.1007/s13300-023-01456-8
- By:
- Publication type:
- Article